NasdaqGM:RDNTHealthcare
Does RadNet’s (RDNT) New Breast AI Suite Subtly Redefine Its Diagnostic Platform Strategy?
Earlier this week, RadNet subsidiary DeepHealth received FDA 510(k) clearances for two new Breast Suite AI tools: Breast Arterial Calcification Assessment and prior exam integration into ProFound Pro (now Mammo Dx), both now commercially available in the United States.
By combining cancer detection support with cardiovascular risk insights in a single workflow, these tools could make RadNet’s breast imaging platform more clinically valuable to both radiologists and referring...